Thymic stromal lymphopoietin (TSLP) has been implicated in primary Sjögren's syndrome (pSS) and related B-cell lymphoproliferation and lymphoma (NHL) by studies on salivary pathologic tissues and serum. The purpose of this work was to validate serum TSLP as biomarker of pSS and related lymphoproliferation by the study of two additional independent cohorts.

Validation of thymic stromal lymphopoietin as a biomarker of primary Sjögren's syndrome and related lymphoproliferation: results in independent cohorts

Ferro, Francesco;Bartoloni, Elena;Baldini, Chiara;Gerli, Roberto;De Vita, Salvatore
2020-01-01

Abstract

Thymic stromal lymphopoietin (TSLP) has been implicated in primary Sjögren's syndrome (pSS) and related B-cell lymphoproliferation and lymphoma (NHL) by studies on salivary pathologic tissues and serum. The purpose of this work was to validate serum TSLP as biomarker of pSS and related lymphoproliferation by the study of two additional independent cohorts.
2020
Gandolfo, Saviana; Fabro, Cinzia; Kapsogeorgou, Efstathia; Colafrancesco, Serena; Ferro, Francesco; Bartoloni, Elena; Quartuccio, Luca; Goules, Andreas; Priori, Roberta; Alunno, Alessia; Conti, Fabrizio; Valesini, Guido; Giacomelli, Roberto; Baldini, Chiara; Gerli, Roberto; Tzioufas, Athanasios G; De Vita, Salvatore
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/1063430
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact